A daily newsletter summarizing recent activity & interesting startups globally


  • WuXi NextCODE, a provider of a global standard platform for genomic data has completed $240M Series B round with investment from a consortium led by Sequoia China and including Temasek, Yunfeng Capital and 3W Partners with participation from Temasek, Yunfeng, 3W and Amgen Ventures. Link
  • Antidote Technologies, which provides a clinical trial matching platform raised $11M in a funding round led by Merck Global Health Innovation Fund (GHI) with participation from investors Smedvig Capital and Octopus Ventures. Link
  • Signet Accel which provides data interoperability solutions to US health systems, consortia, research institutions and biopharma companies raised $8M in a Series-A round led by Edison Partners. Link
  • Moffitt Cancer Center‘s spinoff M2Gen, a provider of healthcare informatics solutions has received a $75M investment from Hearst’s business media channel. Link
  • Deep Genomics, the AI-driven genetic medicine company has raised $13M equity investment led by Khosla Ventures
    with participation from True Ventures. Link
  • Recursion Pharmaceuticals which has developed a proprietary drug discovery platform raised $60M Series B financing led by Data Collective (DCVC). Link
  • Zageno, an online marketplace for Life Sciences research products raised $8M in a Series A investment led by Capnamic Ventures along with Grazia Equity. Link
  • Metabolon, the global leader in metabolomics has acquired metabolomics services and diagnostics company Metabolomic Discoveries for an undisclosed amount. Link
  • Invicro which provides imaging services and software for research and drug development is acquired by Konica Minolta. Link
  • Pilgrim Quality Solutions, a provider of quality and compliance management software and services for Life Sciences has been acquired by an undisclosed US-based strategic acquirer or an undisclosed amount. Link
  • mProve Healthwhich provides mobile technologies for life science companies is acquired by clinical trial technology and specialty services provider, Bracket.


ClosedLoop (2017, Austin) – An AI-based risk predictive platform for payers, providers & pharma companies.
Structura (2016, Toronto) –  A software that uses ML algorithms for drug discovery and research.
Bioxplor (2016, Dusseldorf) – A  Big Data-based virtual laboratory platform with an AI-based biomarker and drug discovery tool.


Metabolon (2000, Durham, $92.42M) provides platforms and informatics systems for biomarker discoveries and diagnostic tests and also offers metabolomics research services. Backed by Aurora Funds, Sevin Rosen Funds, Camden Partners Holdings, Essex Woodlands, HHVC, Sumitomo Corp, Syngenta, Alexandria Real Estate Equities, ATEL Capital Group, Fletcher Spaght, The Trelys Funds, Fulcrum Financial Group, Crossroads Capital.

BioNano Genomics (2003, San Diego, $101.4M) has developed a platform for imaging single molecules of DNA at megabase lengths, allowing the mapping of large chunks of the genome at great resolution.Backed by   National Institutes of Health, Ben Franklin Technology Partners, Legend Capital, KT Venture, 21Ventures, Domain Associates, Innovation Valley Partners, Battelle Ventures, NCI, NHGRI, Novartis Venture Fund, and Monashee Investment
Pacific Biosciences (2004, Menlo Park, Public) has developed a Single Molecule Real Time (SMRT) sequencing platform that utilizes the company’s two proprietary technologies – Zero-Mode Waveguides (ZMW) and phospholinked nucleotides for single molecule sequencing.Backed by Morgan Stanley, Mohr Davidow Ventures, KPCB, DAG Ventures, Maverick Capital, AllianceBernstein, Sutter Hill Ventures, Alloy Ventures, Deerfield Capital Management, Deerfield, and Gen-Probe.
Simulations Plus (1996, Lancaster, Public) develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling & simulation software for cheminformatics and drug discovery and provides consulting services.
Benevolent AI (2013, London, $87.7M) is an Artificial Intelligence company focussed on pharmaceutical R&D and drug discovery. The company has organised itself into two wholly owned, integrated and complementary subsidiaries: ‘BenevolentBio’ (formerly Stratified Medical) – will continue to focus on applying BenevolentAI’s technology in human health and the exploration of further bioscience applications such as veterinary medicine, and ‘BenevolentTech’ – will continue to refine and develop the AI engine that is driving the discoveries in bioscience and in future will look to replicate this success across wider applications and industries.
Inpharmatica (1998, Saffron Walden, $75M, Acq) offers predictive informatics solutions and services for medicinal chemistry and ADME to help improve the speed and productivity of drug discovery. It is also involved in research of drugs and biomarkers. Backed by Vertex Ventures, Advent Venture Partners, Gimv, Gilde, 3i Group, Abingworth, Unibio, and REV. Acquired by Galapagos in Dec 2006.
Schrodinger (1990, New York, $52M) develops software solutions for computational chemistry, research and drug discovery. Backed by Cascade Investment.

Imaging Solutions
Median Technologies (2002, Valbonne, $53.66M, Public) offers medical imaging software and services for oncology clinical trials, cancer screening, and clinical practice. Backed by NEA, Draper Fisher Jurvetson, Auriga Partners, Abingworth, Omega Funds, Idinvest Partners, National Technology Enterprises Company, Kuwait Life Sciences Company (KLSC), and AGF Private Equity.

Aperio Technologies (1999, California, $47.6M, Acq) offers digital pathology solutions including image management, sharing and analysis solutions. Backed by BlackRock, Advanced Technology Ventures, HLM Venture Partners, and Galen Partners. Acquired by Leica Microsystems in Aug 2012.
inviCRO (2008, Boston, $45.8M , Acq ) provides advanced data analysis services and software in the field of preclinical imaging research.Acquired by Konica Minolta in Sep 2017.

Clinical Trial Solutions
Medidata (1999, New York, $66.2M, Public) provides cloud based solutions for clinical trial management and analytics. Backed by Insight Venture Partners, Milestone Venture Partners, Stonehenge Growth Equity, Silicon Alley Venture Partners, The Lambda Funds, State Street, and Alpha Venture Partners and went public in June, 2009.

Parexel (1983, Massachusetts, Public) is a clinical research organization which offers clinical trial management solutions and services. Backed by Capvis.
Datatrak International (1991, Cleveland, Public) offers clinical enterprise solutions which include tools for electronic data capture, trial design, trial supply management and project management.
Comprehend (2010, Palo Alto, $45.9M) provides clinical data reporting and  visualization tools for clinical trials. Backed by Y Combinator, Lightspeed Venture Partners, Sequoia Capital, SV Angel, Menlo Ventures, Crosslink Capital, Quotidian Ventures, Ulu Ventures, Life Sciences Angel Network, and Easton Capital.
Go Balto (2008, San Fransisco, $38.1M) provides cloud-based electronic solutions for clinical trial design, data capture analysis. Backed by Qualcomm, Aberdare Ventures, Mitsui Global Investment, EDBI, West Health, and Dolby Family Ventures.

GRC Solutions
Metric Stream (1999, Palo Alto, $215M) provides solutions for quality management, regulatory compliance, risk management, and corporate governance. Backed by Goldman Sachs, KPCB, Integral Capital Partners, Gold Hill Capital, Sageview Capital, Saints Capital, Kaiser Permanente Ventures, Blade Ventures, Montage Capital, and The Camelot Group.

Virtify (2004, Lexington, $25.1M) provides enterprise content and compliance management solutions for the life sciences industry. Backed by Tudor Growth Equity, Blue Cloud Ventures, and Spring Lake Equity Partners.
Qumas (1994, Cork, $10M, Acq) provides Compliance and Quality Management Software for Life Sciences including solutions for document management, process management and submission management. Backed by  General Catalyst Partners, Fidelity Ventures, Delta Partners, ACT Venture Capital, Fidelity Growth Partners Europe, Kernel Capital, and Eight Roads Ventures. Acquired by Accelrys in Dec, 2013.

Automation Solutions
Emerald Therapeutics (2010, San Francisco, $34M) has developed Emerald Cloud Laboratory that scientists can remotely access via the internet and can perform experiments using automated robotics. Backed by Founders Fund, Western Technology Investment, and Schooner Capital.

Quartzy (2009, Palo Alto, $28.8M) offers web-based platform for lab management and supports collaboration, inventory and order management. It also hosts catalogs from vendors for lab consumables. Backed by  Y Combinator, Lerer Hippeau Ventures, SV Angel, Khosla Ventures, Washington U., Silicon Badia, Reinmkr Satsang, A Capital, Life Science Angels, Science House, Accelerator Tech, Lerer Hippeau Ventures, and Eminence Capital.

Market Intelligence
IMS Health (1954, Danbury, Merged) offers a suite of market intelligence products and services which are aimed at improving productivity and healthcare delivery of healthcare organizations.

CitiusTech (2005, Princeton, $112 M) offers Business Intelligence and healthcare analytics platform. Backed by General Atlantic.
SHYFT Analytics (2005, Waltham, $39M), formerly Trinity Pharma Solutions, provides cloud-based analytics and data management platform for customer engagement and revenue analytics. Backed by Milestone Venture Partners, Health Enterprise Partners, Medidata, and McKesson Ventures.
Zephyr Health (2011, San Francisco, $33.5 M) offers Zephyr Illuminate, an Insights-as-a-Service platform designed to help companies improve product life cycle performance with customer and market insights and can be used for collaboration, targeting and segmentation, and planning. Backed by KPCB, Jafco Ventures, and Icon Ventures.

Sales and Marketing
Veeva Systems (2007, San Francisco, $ 4 M, Public) offers Content Management, Customer Relationship Management, Customer Master data management and related software and services to the life sciences industry. Backed by  Lead Edge Capital, and Emergence Capital. Went public in October 2013.

Aktana (2008, San Francisco, $25 M) offers sales force solutions and customer relationship management solutions for life sciences industry. Backed by Safeguard Scientifics, and Starfish Ventures.

Operations Management and Supply Chain
Tracelink (2009, Woburn, $77 M) offers an online platform for global distribution, visibility and traceability of pharmaceuticals to limit the sale of counterfeit drugs. Backed by FirstMark Capital, Goldman Sachs, Volition Capital, and F-Prime Capital Partners.

Bluechiip (2003, Scoresby, Public) provides wireless tracking solutions for bio samples and other products. Went public in Oct, 2010 via a reverse takeover by Sofcom Limited.

Leaderboard includes all the top funded, IPO and successfully running bootstrapped companies along with their location, founding year and funding amount.

For latest updates, visit Life Sciences – Software feed.

Leave a Reply